Immune trade-offs of chronic low-dose rapamycin in healthy adults: a cautionary survey

Argues low-dose rapamycin protocols circulating online run ahead of immune-safety surveillance; flags infection-risk windows.

• 01Design: Narrative review — weighted accordingly in our rubric.
• 02Solid design; some limitations on generalizability or duration.
• 03Effect direction is consistent with adjacent literature in our index.

Native comments, Twitter mentions, and Reddit threads about this paper — surfaced together so the conversation isn't fragmented across platforms.